Cargando…
P51 EFFICACY AND SAFETY OF THIRD-LINE OR LATER TREATMENTS, INCLUDING THE CD38 MONOCLONAL ANTIBODY CLASS, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SYSTEMATIC LITERATURE REVIEW
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171565/ http://dx.doi.org/10.1097/01.HS9.0000936332.73280.e0 |
| _version_ | 1785039446253502464 |
|---|---|
| author | Hanna, M. Chorazy, J. Iheanacho, I. Gorsh, B. Wang, P.F. Paka, P. Perera, S. |
| author_facet | Hanna, M. Chorazy, J. Iheanacho, I. Gorsh, B. Wang, P.F. Paka, P. Perera, S. |
| author_sort | Hanna, M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10171565 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101715652023-05-11 P51 EFFICACY AND SAFETY OF THIRD-LINE OR LATER TREATMENTS, INCLUDING THE CD38 MONOCLONAL ANTIBODY CLASS, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SYSTEMATIC LITERATURE REVIEW Hanna, M. Chorazy, J. Iheanacho, I. Gorsh, B. Wang, P.F. Paka, P. Perera, S. Hemasphere Poster Lippincott Williams & Wilkins 2023-05-09 /pmc/articles/PMC10171565/ http://dx.doi.org/10.1097/01.HS9.0000936332.73280.e0 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Poster Hanna, M. Chorazy, J. Iheanacho, I. Gorsh, B. Wang, P.F. Paka, P. Perera, S. P51 EFFICACY AND SAFETY OF THIRD-LINE OR LATER TREATMENTS, INCLUDING THE CD38 MONOCLONAL ANTIBODY CLASS, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SYSTEMATIC LITERATURE REVIEW |
| title | P51 EFFICACY AND SAFETY OF THIRD-LINE OR LATER TREATMENTS, INCLUDING THE CD38 MONOCLONAL ANTIBODY CLASS, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SYSTEMATIC LITERATURE REVIEW |
| title_full | P51 EFFICACY AND SAFETY OF THIRD-LINE OR LATER TREATMENTS, INCLUDING THE CD38 MONOCLONAL ANTIBODY CLASS, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SYSTEMATIC LITERATURE REVIEW |
| title_fullStr | P51 EFFICACY AND SAFETY OF THIRD-LINE OR LATER TREATMENTS, INCLUDING THE CD38 MONOCLONAL ANTIBODY CLASS, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SYSTEMATIC LITERATURE REVIEW |
| title_full_unstemmed | P51 EFFICACY AND SAFETY OF THIRD-LINE OR LATER TREATMENTS, INCLUDING THE CD38 MONOCLONAL ANTIBODY CLASS, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SYSTEMATIC LITERATURE REVIEW |
| title_short | P51 EFFICACY AND SAFETY OF THIRD-LINE OR LATER TREATMENTS, INCLUDING THE CD38 MONOCLONAL ANTIBODY CLASS, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SYSTEMATIC LITERATURE REVIEW |
| title_sort | p51 efficacy and safety of third-line or later treatments, including the cd38 monoclonal antibody class, in patients with relapsed/refractory multiple myeloma: a systematic literature review |
| topic | Poster |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171565/ http://dx.doi.org/10.1097/01.HS9.0000936332.73280.e0 |
| work_keys_str_mv | AT hannam p51efficacyandsafetyofthirdlineorlatertreatmentsincludingthecd38monoclonalantibodyclassinpatientswithrelapsedrefractorymultiplemyelomaasystematicliteraturereview AT chorazyj p51efficacyandsafetyofthirdlineorlatertreatmentsincludingthecd38monoclonalantibodyclassinpatientswithrelapsedrefractorymultiplemyelomaasystematicliteraturereview AT iheanachoi p51efficacyandsafetyofthirdlineorlatertreatmentsincludingthecd38monoclonalantibodyclassinpatientswithrelapsedrefractorymultiplemyelomaasystematicliteraturereview AT gorshb p51efficacyandsafetyofthirdlineorlatertreatmentsincludingthecd38monoclonalantibodyclassinpatientswithrelapsedrefractorymultiplemyelomaasystematicliteraturereview AT wangpf p51efficacyandsafetyofthirdlineorlatertreatmentsincludingthecd38monoclonalantibodyclassinpatientswithrelapsedrefractorymultiplemyelomaasystematicliteraturereview AT pakap p51efficacyandsafetyofthirdlineorlatertreatmentsincludingthecd38monoclonalantibodyclassinpatientswithrelapsedrefractorymultiplemyelomaasystematicliteraturereview AT pereras p51efficacyandsafetyofthirdlineorlatertreatmentsincludingthecd38monoclonalantibodyclassinpatientswithrelapsedrefractorymultiplemyelomaasystematicliteraturereview |